Publications by authors named "M Khalili"
Alzheimer's disease (AD) is a prevalent neurodegenerative disorder in elderly. The neurotoxicant trimethyltin (TMT) induces neurodegenerative changes, as observed in AD. The 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitor simvastatin (SV) has shown protective and promising therapeutic effects in neurological disorders such as AD and Parkinson's disease.
View Article and Find Full Text PDFBackground & Objective: FFA usually has a gradual subtle course and might be overlooked by physicians or misdiagnosed with other types of hair loss including androgenetic alopecia, traction alopecia, and other types of patterned alopecia. In this study, we described clinicopathological features of patients with FFA referring for skin biopsy.
Methods: This is a retrospective cross-sectional study on 26 patients with a diagnosis of FFA based on clinicopathological features.
Article Synopsis
- Arterial ischemic stroke (AIS) in children, especially those with childhood leukemia, is a rare but serious condition that can lead to long-term disabilities, with a lack of established guidelines for treating it in pediatric patients.
- A case of a 13-year-old girl with acute lymphoblastic leukemia highlights successful mechanical thrombectomy using advanced devices, which allowed for effective recanalization of affected arteries.
- Despite emerging evidence supporting mechanical thrombectomy for children with AIS, definitive guidelines are still lacking, emphasizing the need for urgent, specialized care by a multidisciplinary team for optimal patient outcomes.*
Significant Disparities in Hepatocellular Carcinoma Outcomes by Race/Ethnicity and Sociodemographic Factors.
Cancer Epidemiol Biomarkers Prev
December 2024
Background: Hepatocellular carcinoma (HCC) disproportionately affects racial/ethnic minorities. We evaluated the impact of income and geography on racial/ethnic disparities across the HCC care cascade in the U.S.
View Article and Find Full Text PDFArticle Synopsis
- Treatment for alcohol use disorder (AUD) is important for improving health outcomes in patients with alcohol-associated cirrhosis, yet it remains underutilized, especially among socioeconomically disadvantaged groups.
- A study of 196 diverse patients revealed that 67% had ever utilized AUD treatment, while only 32% accessed treatment in the last year; younger patients and those with worse mental health symptoms were more likely to seek treatment.
- Factors such as older age and better liver disease quality of life were associated with lower treatment utilization, while those with significant anxiety or depression tended to seek treatment more frequently.